Mitochondria are far more than the “powerhouse” of the cell as they have classically been described. In fact, mitochondria biological activities have progressively expanded to include not only various bioenergetic processes but also important biosynthetic pathways, calcium homeostasis and thermogenesis, cell death by apoptosis, several different signal transduction pathways mainly related to redox control of gene expression and so on. This functional and structural complexity may undergo important derangements so to justify the definition of ‘mitochondrial medicine’, which should include all the clinical consequences of congenital or acquired mitochondrial dysfunctions. There are actually a growing number of studies which assign a significant pathogenic role to damaged mitochondria in different diseases: ischemia/reperfusion injury, neurodegenerative diseases, metabolic syndrome, hyperlipidemias, just to mention a few of the most important pathologies. In this context, a further aspect that should not be disregarded is the interaction of pharmacological agents with mitochondria, not only in regard of the toxicological aspects but, above all, of the potential therapeutic applications. In fact, it is interesting to note that, while the properties of different so-called “mitoxicants” are well-known from a physical, chemical and biochemical point of view, the often subtle linkages between drugs and mitochondria is still in need of a real pharmacological and therapeutic control at the clinical level. This lack of consideration can often lead to an underestimation of unwanted toxic effects but also of desirable therapeutic activities, both diverging outcomes resulting from drug induced modification of mitochondrial homeostasis. The aim of this book is to stimulate a re-evaluation of the potential clinical role of mitochondria that could shed new light on some yet debated aspects of human pathophysiology

Scatena, R., Bottoni, P., Giardina, B., Advances in Mitochondrial Medicine, Springer, DORDRECHT -- NLD 2012:<<ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY>>,942 492 [http://hdl.handle.net/10807/10801]

Advances in Mitochondrial Medicine

Scatena, Roberto;Bottoni, Patrizia;Giardina, Bruno
2012

Abstract

Mitochondria are far more than the “powerhouse” of the cell as they have classically been described. In fact, mitochondria biological activities have progressively expanded to include not only various bioenergetic processes but also important biosynthetic pathways, calcium homeostasis and thermogenesis, cell death by apoptosis, several different signal transduction pathways mainly related to redox control of gene expression and so on. This functional and structural complexity may undergo important derangements so to justify the definition of ‘mitochondrial medicine’, which should include all the clinical consequences of congenital or acquired mitochondrial dysfunctions. There are actually a growing number of studies which assign a significant pathogenic role to damaged mitochondria in different diseases: ischemia/reperfusion injury, neurodegenerative diseases, metabolic syndrome, hyperlipidemias, just to mention a few of the most important pathologies. In this context, a further aspect that should not be disregarded is the interaction of pharmacological agents with mitochondria, not only in regard of the toxicological aspects but, above all, of the potential therapeutic applications. In fact, it is interesting to note that, while the properties of different so-called “mitoxicants” are well-known from a physical, chemical and biochemical point of view, the often subtle linkages between drugs and mitochondria is still in need of a real pharmacological and therapeutic control at the clinical level. This lack of consideration can often lead to an underestimation of unwanted toxic effects but also of desirable therapeutic activities, both diverging outcomes resulting from drug induced modification of mitochondrial homeostasis. The aim of this book is to stimulate a re-evaluation of the potential clinical role of mitochondria that could shed new light on some yet debated aspects of human pathophysiology
Inglese
Monografia o trattato scientifico
Scatena, R., Bottoni, P., Giardina, B., Advances in Mitochondrial Medicine, Springer, DORDRECHT -- NLD 2012:<<ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY>>,942 492 [http://hdl.handle.net/10807/10801]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/10801
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact